Activist investor Politan seeks two more board seats at medical tech company Masimo, aiming to oust CEO Joe Kiani and increase shareholder value.
Masimo activist Politan renews push for change at medical tech company, aiming to win two more board seats, oust CEO Joe Kiani, and deliver $10B in shareholder value through improved governance. Despite winning two seats last year, shareholders' concerns remain unaddressed, prompting Politan to nominate two more directors. Masimo shares have dropped 18% since last year's meeting.
June 26, 2024
3 Articles